Corporate Profile

HCW Biologics is developing transformative immunotherapies to lengthen healthspan by disrupting inflammaging.

HCW Biologics is an innovative immunotherapy company developing novel therapeutics designed to disrupt the link between chronic, low-grade inflammation and age-related disorders. This field, known as inflammaging, targets the unresolved inflammatory responses and chronic, low-grade inflammation associated with advancing age and believed to be a significant contributing factor to cancer and several chronic conditions, including cardiovascular disease, diabetes, neurodegenerative disease, and autoimmune disease.


HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index

Data Provided by Refinitiv. Minimum 15 minutes delayed.